bioRxiv · 10.64898/2026.07.02.736124
Humanized tauopathy chimeras uncover microglial and lncRNA strategies for neuroprotection
Abstract
Human genetics implicates innate immunity as a key modifier of tau toxicity, yet human-specific neuroimmune mechanisms remain difficult to test in vivo. Here, we developed HuMiNAX, the first humanized iPSC-based neuroimmune xenograft model of tau-associated neurodegeneration, enabling human microglia to interact with human neurons and astrocytes in the adult mouse brain. In HuMiNAX, tau seeding induced aggregation only in mutation-carrying human neural grafts, causing neuron loss and inflammatory activation of human microglia. Progranulin-overexpressing human microglia dampened tau-associated inflammation, preserved neurons, and restored neuronal gene-expression and RNA-splicing programs, supporting microglial control of neuronal resilience. CRISPRi knockdown of the human-specific lncRNA HNRNPK-AS1 also protected neurons in HuMiNAX. These findings establish HuMiNAX as a human neuroimmune model of tauopathy and identify microglial and RNA-mediated strategies of neuronal resilience.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Qu, W., Fan, L., Jang, M. W., Ye, P., Cordes, E., Aikedan, A., Hu, W., Nagiri, R. K., Wong, M. Y., Luo, W., Blurton-Jones, M., Tilgner, H. U., Orr, A. G., Gong, S., Gan, L.. 2026-07-03. Humanized tauopathy chimeras uncover microglial and lncRNA strategies for neuroprotection. https://doi.org/10.64898/2026.07.02.736124
Cite the original work for its findings. Save a collection to share your selection of sources.